POSTER SESSION 4: Epilepsy: Medical and Surgical Treatment, Neuro-Oncology, Neuropsychiatry
Tracks
POSTER AREA
| Thursday, September 19, 2019 |
| 12:15 PM - 1:00 PM |
| POSTER AREA (Balcony Muses Foyer) |
Overview
P04-01 to P04-35
Speaker
Dr. Aharon Schif
Rambam Medical Center
P04-01 | KCNT1 related severe Early Onset Epilepsy – A promising example of Precision Medicine
Dr. Barbora Benova
Department Of Paediatric Neurology, 2nd Faculty Of Medicine, Charles University And Motol University Hospital
P04-02 | T2w Hypointense MRI Lesions may represent an early marker of the Epileptogenic Zone in infants with Tuberous Sclerosis Complex. A case series
Prof. Berten Ceulemans
Department of Paediatric Neurology, University Hospital and University of Antwerp
P04-03 | Fenfluramine HCl oral solution provides long-term, clinically meaningful (≥50%) reduction in seizure frequency in Dravet Syndrome: interim analysis of a long-term open-label extension study
Dr. Chrysoula Michaletou
Children's Hospital Agia Sofia
P04-04 | Suspected Autoimmune Epilepsy in children
Dr. Dídac Casas-Alba
Hospital Sant Joan De Déu
P04-05 | KCNQ2-Related Disorders: clinical spectrum and response to sodium channel blockers
Dr. Leock (Stella) Ngo
Eisai Inc.
P04-06 | Adjunctive Perampanel and Health-Related Quality of Life (HRQoL) in paediatric patients (aged 4 to <12 years) with Partial-Onset Seizures (POS) or Primary Generalised Tonic-Clonic Seizures (PGTCS) in Study 311
Mrs. Elke Braat
Uz Leuven
P04-07 | A boy with Febrile Infection-related Epilepsy Syndrome (FIRES) treated with a Human Recombinant IL-1 receptor antagonist, a promising treatment option?
Ms. Elżbieta Stawicka
Public Pediatric Teaching Clinical Hospital in Warsaw
P04-08 | Preliminary results of the project: "Supporting a Pilot Program for the Creation of Medical Centre Specialized in Diagnosis and Therapy for Children with Fetal Alcohol Spectrum Disorder (FASD)"
Prof. Eu Gene Park
Incheon St. Mary's Hospital, The Catholic University of Korea, College of Medicine
P04-09 | Clinical characteristics of Tic Disorders in children
Prof. Fenella Kirkham
University College London, United Kingdom
P04-10 | Long-term efficacy and safety of Eslicarbazepine Acetate in children: an open-label extension following the double-blind, randomized, placebo-controlled study
Dr. Giulia Prato
G.gaslini Institute
P04-11 | Neurological and neuropsychological assessment in young children with Isolated Basal Ganglia Stroke
Dr. Gulten Ozturk Thomas
Marmara University
P04-12 | Ketogenic diet experience of our clinic in Epileptic Encephalopathy patients
Dr. Hideki Uchikawa
Eastern Chiba Medical Center
P04-13 | Specific personality and amygdala volume in Gorlin Syndrome
Dr. Jamie Shah
Birmingham Childrens Hospital
P04-14 | Our experience of Perampanel, a newer Antiepileptic Drug (AED), in the treatment of children with difficult to manage Epilepsy – A 4-year retrospective, single quaternary centre study
Dr. Jung Chieh Du
Pediatric Department/Taipei City Hospital
P04-15 | The association of EEG abnormalities and core symptoms in children with Attention-Deficit/Hyperactivity Disorder
Prof. Katalin Hollody
Department of Paediatrics, Clinical Center, University Of Pécs, Medical School
P04-16 | Childhood Absence Epilepsy. Does it really have a good prognosis?
Dr. Keren Politi
Schneider's Children Medical Center
P04-17 | Amantadine – An optional treatment for Sever Secondary Myoclonic Epilepsy and Hyperkinetic Dyskinesia
Dr. Kimford Meador
Stanford University School Of Medicine, Stanford Neuroscience Health Center
P04-18 | Effects of Adjunctive Perampanel on neuropsychological and growth development in paediatric patients (aged 4 to ˂12 years) with Partial-Onset Seizures (POS) or Primary Generalised Tonic-Clonic Seizures (PGTCS)
Dr. Jurgis Strautmanis
University Children's Clinical Hospital
P04-19 | Co-infection Neuroborreliosis and Ehrlichiosis mimicking Paraneoplastic Syndrome – Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM) in teenage girl
Prof. Patrick Van Bogaert
Chu Angers
P04-20 | Anti-epileptic drugs do not resolve impaired memory consolidation in Idiopathic Epilepsy Syndromes of childhood
Dr. Marco Perulli
Catholic University Of Sacred Heart- Rome
P04-21 | Potassium Bromide in Dravet Syndrome and Lennox-Gastaut Syndrome: an underutilized option?
Ms. Natalia Natrusova
Morozov City Children Hospital
P04-22 | «Masks» of Ischemic Stroke in children with malignancies
Dr. Natasha Schoeler
Ucl Great Ormond Street Institute Of Child Health
P04-23 | Use of a medium chain Triglyceride-based food for special medical purposes in children with Epilepsy: compliance, tolerability and acceptability
Dr. Nihal Olgac Dundar
Izmir Katip Celebi University
P04-24 | Comparison of neurocognitive outcomes between Levetiracetam and Phenobarbital monotherapy for the treatment of neonatal seizures
Mrs. Joana Moreira
Bial Portela & Cª, SA
P04-25 | Long-term therapeutic effect of Eslicarbazepine Acetate in children: an open-label extension of cognition study in children 6-16 years
Dr. Manoj Malhotra
Eisai
P04-26 | Study 311: evaluation of adjunctive Perampanel on mental health in children (aged 4 to <12 years) with Partial-Onset Seizures (POS) or Primary Generalised Tonic-Clonic Seizures (PGTCS)
Dr. Stefano Catanzaro
Unit Of Rare Diseases Of The Nervous System In Childhood, University Of Catania, Catania (Italy)
P04-27 | Natural History of “Congenital” Neurofibromatosis Type 2 (NF2)
Dr. Stavroula Anastasopoulou
Karolinska Institute
P04-28 | Seizures in children with Acute Lymphoblastic Leukaemia: incidence, risk factors, aetiology and prognosis
Dr. Maria Spanou
Attikon University Hospital
P04-29 | A retrospective study of effectiveness and compliance of Ketogenic diet in a single unit
Mrs. Sophia Bakhtadze
Tbilisi State Medical University
P04-30 | Impact of Methylphenidate on cognitive profile in children with Attention Deficit Hyperactivity Disorder
Dr. Marina Caner Faig
Hospital General De Granollers
P04-31 | Description of the use of Levetiracetam in a cohort of Neonatal Onset Epileptic Encephalopathies
Prof. Dorota Dunin-Wasowicz
The Children's Memorial Health Institute
P04-32 | Treatment with Adrenocorticotropin hormone in Drug Resistant Epilepsy – Efficacy in very young infants and older children
Prof. Omnia El Rashidy
Ain Shams University
P04-33 | Estimation of Malondialdehyde, total antioxidant capacity, and Selenium levels in serum of intractable epileptic children receiving treatment with Ketogenic diet
Prof. Vlasta Duranovic
Children's Hospital Zagreb
P04-34 | Hemimegalencephaly and Epilepsy
Dr. Rok Kucan
University Children's Hospital Ljubljana
P04-35 | A case of rapidly progressing Pineal Cyst – Is it Pineoblastoma?
Chair
Efterpi Pavlidou
University General Hospital AHEPA, Thessaloniki, Greece
Georgia Ramantani
Neuropediatrics, University Childrens Hospital Zurich
